Viral vectors expressing fusion of viral large envelope protein and protein of interest

Details for Australian Patent Application No. 2004231119 (hide)

Owner Hepgenics Pty Ltd

Inventors Anderson, David Andrew; Grgacic, Elizabeth Vera Ludmilla

Agent Davies Collison Cave

Pub. Number AU-B-2004231119

PCT Pub. Number WO2004/092387

Priority 2003901876 17.04.03 AU

Filing date 16 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 4 September 2008

International Classifications

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/092387 Priority application(s): WO2004/092387

4 September 2008 Application Accepted

  Published as AU-B-2004231119

8 January 2009 Standard Patent Sealed

15 March 2012 Assignment Registered

  Hepgenics Pty Ltd The patent has been assigned to ARTES Biotechnology GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004231120-Determining gas volume, porosity, and intrinsic oxidation rate

2004231118-Method and apparatus for testing fibres